This tutorial provides a comprehensive guide to setting up and utilizing OpenClaw AI agents for managing autonomous cryptocurrency wallets on both the Base and Solana networks. You will learn how to ...
A new organization blessed by the president is raising money for events and projects that will put a Trumpian spin on the nation’s semiquincentennial. By Kenneth P. Vogel Lisa Friedman and David A.
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...
Jan 13 (Reuters) - U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen (AMGN.O), opens new tab to examine challenges patients and providers face in ...
Monday - Friday, 6:00 - 7:00 PM ET In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the pharmaceutical giant's new pill format of its weight loss drug will allow ...
Suzuki Motorcycle India has launched its first electric scooter in the Indian market called the e-Access. Introduced at Rs 1.88 lakh (ex-showroom), the electric two-wheeler will be manufactured at the ...
The Suzuki e-Access has a claimed range of just 95km on a single full charge. Suzuki starts bookings for its first electric scooter, e-Access, priced at Rs 1,88,490. e-Access has a 3.07kWh LFP battery ...
Suzuki has opened bookings for its first electric scooter, the Suzuki e-Access, marking the brand’s entry into the Indian electric two-wheeler market. We reviewed the e-Access early last year and the ...
Suzuki has finally launched the e-Access electric scooter in India at a surprising price of Rs 1,88,490 (ex-showroom, Delhi). Bookings are now open across all authorised Suzuki dealerships in the ...
BENGALURU: Space engineering firm Dhruva Space Thursday announced Polar Access-1 (PA-1), its most integrated launch programme so far, under which it will support 10 space missions serving multiple ...
The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. The Centers for Medicare & Medicaid Services (CMS) on Tuesday announced the Better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results